<DOC>
	<DOCNO>NCT02659995</DOCNO>
	<brief_summary>Our multicenter prospective observational study aim show relationship blood glucose level glycemic variability development infection ICU stay outcome . Within secondary endpoint , evaluate blood glucose range 70 140 mg/dl associate increase survive rate non-diabetic critically ill patient . MATERIALS AND METHODS Multicenter study ( ICUs Italian University Hospitals ) . Written inform consent request inclusion patient study ; possible , informing module give patient 's family inform consent request patient soon possible . Inclusion criterion : 300 patient consecutively admit ICU January 2016 later 31/03/2017 . Exclusion criterion : age &lt; 18 , end-stage disease . Data collection An Excel database edit data patient : age , sex , type I II diabetes , glycated hemoglobin , at-home antidiabetic therapy ; admission diagnosis , admission SAPS II score ; daily insulin administration ( dose route administration , time start , dose moment glycemic measurement min-max daily range ) ; steroid therapy ( molecule , daily dose , date start stop ) ; antibiotic therapy ( molecule , daily dose , date start stop ) ; daily caloric protein intake type nutrition ; therapy ; mechanical ventilation ( date start stop ) ; blood lactate ( bad daily value ) ; daily leucocytes differential white cell count ; daily SOFA score ; presence infection ( suspect confirm ; site microorganism eventual Multidrug Resistance pattern ) ; presence sepsis ( follow SCCM criterion ) ; length ICU hospital stay ; outcome ( ICU hospital mortality ) . Every blood glucose level measurement obtain registered date time . Glycemic variability evaluate term : - Standard deviation ( SD ) - Mean Amplitude Glycemic Excursions ( MAGE ) ; - Coefficient Variation ( CV ) ; - Glycemic Lability Index ( GLI ) . STATISTICAL ANALYSIS Data analysis perform Kolmogorov-Smirnov test ; parametric non-parametric test , t-test ( Mann-Whitney test ) , ROC Curve , binary logistic regression . Subgroups analysis . Statistical significance : p &lt; 0,05 . SAMPLE SIZE 3300 patient .</brief_summary>
	<brief_title>Relationship Between Blood Glucose Levels Variability Infections Development Critically Ill Patient</brief_title>
	<detailed_description>INTRODUCTION High blood glucose level insulin resistance frequently register critically ill patient . In past , hyperglycemia due stress consider adaptive body reaction satisfy higher energetic request . This theory re-discussed Leuven 's study 2001 , demonstrate strict glycemic control , mean intensive insulin administration , may reduce mortality critically ill patient . However , recent randomize controlled study confirm result , show intensive insulinic therapy associate high risk hypoglycemia death . Recently , attention shift issue glycemic variability Intensive Care Units ( ICU ) , seem good mortality predictor simple blood glucose level . A relationship low glycemic variability , normal glucose level ( range 72-125 mg/dl ) outcome improve investigate . An high glycemic variability 's associate increase in-hospital mortality , also patient total parenteral nutrition ( TPN ) independently presence episode hypo hyperglycemia . Furthermore , intensive insulinic therapy may lead excessive blood glucose level fluctuation brings increase risk hypoglycemia , usually treat `` aggressive '' way . A recent retrospective study evaluate impact glycemic variability hypoglycemia outcome non critically ill patient ( undergone insulin administration hospitalization ) , show strong correlation hypoglycemia increase mortality rate . A recent work Arnold coll . show application treatment protocol hypoglycemia ( use administration 50 % dextrose ) critically ill patient able obtain reduction glycemic variability , remain safe avoid dangerous hypoglycemia . However , real causal relationship glycemic variability mortality yet demonstrate . The increased oxydative stress due wide glycemic fluctuation seem play lead role . The altered glucidic homeostasis critically ill patient may also cause disfunction immune cell increase risk infection : Hirshberg et al . find association glycemic variability risk nosocomial infection development population pediatric critically ill patient , study retrospectively . A correlation high glycemic variability , development sepsis risk nosocomial infection burn patient also demonstrate . Recently , study Krinsley Preiser highlight keep blood glucose level range 70 140 mg/dl strongly associate increase survive rate non diabetic patient , independently ICU length stay severity clinical condition . Donati et al . demonstrate , retrospective study , relationship glycemic variability infection ; however , 's yet clear glycemic variability cause effect infection . Indeed , `` relationship '' equivalent `` causality '' 's yet elucidate high glycemic variability represent sign bad clinical condition , conversely , really lead increase risk nosocomial infection . In last case , dedicate protocol mandatory , normalize blood glucose level also minimize excessive glycemic fluctuation . STUDY PURPOSE Primary endpoint multicenter prospective observational study evaluate relationship blood glucose level glycemic variability development nosocomial infection ICU stay . Secondary endpoint : To confirm correlation blood glucose level outcome ( ICU mortality hospital mortality ) . To evaluate keep blood glucose level range 70 140 mg/dl associate increase survive rate non diabetic critically ill patient . PRIMARY ENDPOINT : Evaluation discriminatory power Glycemic Lability Index ( GLI ) infection development AUC ( ROC curve ) . SECONDARY ENDPOINTS : Evaluation discriminatory power index glycemic variability infection development . Evaluation discriminatory power glycemic variability index mortality . Evaluation eventual difference diabetic non diabetic patient infection development . Evaluation impact caloric intake glycemic variability , infection development mortality . MATHERIALS AND METHODS The study take place ICUs participating center . Written formal inform consent request inclusion patient study ; wo n't possible particular neurologic condition patient , inform module provide patient 's family inform consent request patient soon possible . Inclusion criterion : 300 patient consecutively admit participate ICUs January 2016 later 31/03/2017 . Exclusion criterion : age &lt; 18 , patient end-stage disease life expectancy shorter 24 hour . Data collection An Excel database edit , collect data patient : age , sex , presence type I II diabetes , glycate haemoglobin ( present ) , at-home antidiabetic therapy ( include oral antidiabetic dose insulin ) ; admission diagnosis , admission SAPS II score ; every day ICU stay register : insulin administration ( `` one-shot '' administration , dose route administration , infusion , time start , dose moment glycemic measurement min-max daily range ) ; steroid therapy ( molecule , daily dose , date start stop ) ; antibiotic therapy ( molecule , daily dose , date start stop ) ; daily caloric proteic intake specify via enteral parenteral nutrition ; therapy include glucose propofol ; mechanical ventilation ( yes/no , date start stop ) ; blood lactate ( bad daily value ) ; daily leucocytes differential white cell count ; daily SOFA score ; presence infection ( suspect confirm ; confirm , site microorganism eventual Multidrug Resistance pattern ) ; presence sepsis ( follow SCCM criterion ) ; length ICU hospital stay ; outcome ( ICU hospital mortality ) . Every blood glucose level measurement obtain laboratory analysis , bloodgas analysis Glucostix , register date time ( hour minute ) . Glycemic variability evaluate term four index : Standard deviation ( SD ) Mean Amplitude Glycemic excursion - MAGE , calculate mean difference consecutive value blood glucose ( absolute value ) &gt; 1 SD global value ; Coefficient Variation ( CV ) calculate SD/mean . Glycemic Lability Index ( GLI ) calculate follow formule ( Gluc n number value register time H n e N total number value register week ; measurement interval 1 12 hour register ; mean GLI different week calculate ) . GLI ( ( mmol⁄l^2 ) ⁄h*〖week〗^ ( -1 ) ) =∑_ ( n=1 ) ^N▒〖 ( 〖Gluc〗_n-〖Gluc〗_ ( n+1 ) ) 〗^2⁄ ( ( h_ ( n+1 ) -h_n ) ) STATISTYCAL ANALYSIS All patient ICU length stay shorter 72 hour exclude statistical analysis primary endpoint . Based earlier study , 40 % admitted patient length stay shorter 3 day incidence infection 30 % . For reason 's calculate necessary include 2928 patient alpha error &lt; 0,01 beta error &lt; 0,01 , exclude every patient ICU stay shorter 72 hour . Considering variability length ICU stay single ICUs possibility date 31/03/2017 ICUs could reach possibility admit 300 patient , theorical sample size expand 3300 patient total ( 20 % theorical sample ) . The variable distribution evaluate Kolmogorov-Smirnov test ; parametric non parametric statistical test applicated appropriate . T-Test ( Mann-Whitney test ) use variable comparison group `` infections/no infection '' , `` sepsis/no sepsis '' , `` survivors/non survivor '' . ROC curve ( Receiver Operating Characteristics ) make evaluate discriminatory power blood glucose level , SD , MAGE , CV GLI infection development , sepsis outcome . Binary logistic regression applicated analyze correlation glycemic variability , infection development , sepsis outcome , include APACHE II , SOFA , age , sex , presence diabetes , blood lactate ( admission mean value ) , insulin administration , type nutrition , mechanical ventilation length ICU stay covariates . Subgroups analysis perform base admission diagnosis , presence diabetes , insulin administration ICU , type nutrition . Statistical significance consider p value &lt; 0,05 . SAMPLE SIZE 3300 patient .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>All patient admit ICU age &lt; 18 , patient endstage disease life expectancy shorter 24 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>glycemic variability</keyword>
	<keyword>infection</keyword>
</DOC>